Compare · APDN vs IT
APDN vs IT
Side-by-side comparison of Applied DNA Sciences Inc. (APDN) and Gartner Inc. (IT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APDN and IT operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- IT is the larger of the two at $8.95B, about 373.6x APDN ($24.0M).
- Over the past year, APDN is up 7.8% and IT is down 62.5% - APDN leads by 70.3 points.
- IT has hit the wire 16 times in the past 4 weeks while APDN has been quiet.
- IT has more recent analyst coverage (25 ratings vs 2 for APDN).
- Company
- Applied DNA Sciences Inc.
- Gartner Inc.
- Price
- $5.67+31.25%
- $133.68+1.05%
- Market cap
- $24.0M
- $8.95B
- 1M return
- +142.31%
- +3.46%
- 1Y return
- +7.79%
- -62.49%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 1993
- News (4w)
- 0
- 16
- Recent ratings
- 2
- 25
Applied DNA Sciences Inc.
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Gartner Inc.
Gartner, Inc. operates as a research and advisory company in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Research, Conferences, and Consulting. The Research segment offers objective insights and advice on the priorities of various leaders in a range of functional areas of the enterprise through reports, briefings, proprietary tools, access to research expert, peer networking services, and membership programs that enable clients to drive organizational performance. This segment delivers its research primarily through a subscription service. The Conferences segment offers business professionals in an organization the opportunity to learn, share, and network. The Consulting segment offers market research, custom analysis, and on-the-ground support services. This segment also offers actionable solutions for IT-related priorities, including IT cost optimization, digital transformation, and IT sourcing optimization. Gartner, Inc. was founded in 1979 and is headquartered in Stamford, Connecticut.
Latest APDN
- SEC Form DEFA14A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Leadership Update
- SEC Form DEF 14A filed by Applied DNA Sciences Inc.
- SEC Form 424B5 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Applied DNA Sciences Inc.
- SEC Form S-1 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest IT
- Gartner to Report Second Quarter 2026 Financial Results on August 4, 2026
- Gartner Announces the Gartner Enterprise Risk, Audit & Compliance Conference 2026 in Grapevine
- Gartner Announces Gartner IT Symposium/Xpo, October 19-22, in Orlando
- SEC Form 4 filed by Director Dykstra Karen E
- SEC Form 4 filed by Director Serra Eileen
- SEC Form 4 filed by Director Rus Daniela L
- Director Pagliuca Stephen G acquired 187 shares, increasing direct ownership by 0.17% to 112,602 units (SEC Form 4)
- Director Gutierrez Jose M acquired 112 shares, increasing direct ownership by 4% to 2,951 units (SEC Form 4)
- Director Grabe William O acquired 182 shares, increasing direct ownership by 17% to 1,224 units (SEC Form 4)
- Director Fuchs Anne Sutherland acquired 100 shares, increasing direct ownership by 1% to 8,957 units (SEC Form 4)